Business Development

Mark Chadwick leads Arcivova's business development.  Arcinova also works in close partnership with Covance's sales team to deliver integrated solutions.


Mark Chadwick

Head of Business Development

Originally a molecular biologist, Mark has spent 18 years in the drug discovery and development industry in both project management and commercial roles.  Previous relevant positions include CEO at AIM-listed Physiomics plc, VP Business Development at Excelsyn and Director of Commercial Operations at BioFocus. 

Mark holds a degree in Genetics from the University of Nottingham, a PhD in Molecular Biology from the University of Newcastle and an MBA from Imperial College London.

"Throughout my career I have always been passionate about providing drug discovery and development services to customers. I gain a great deal of satisfaction from collaborating with biotechnology and pharmaceutical companies and being part of a team who deliver solutions that are often of critical importance to our partners."

Faye Coates

Commercial Operations Officer

After graduating in 2012, Faye has gained experience in Marketing and Events Management. Her previous roles have all been client centric, focussing on business development and sales.

Faye is a qualified project manager and holds an honours degree in Business with Marketing and an MSc in Project Management, both of which are from Northumbria University.

"We are very focussed on responding to customer enquiries, listening to their requirements and delivering on those in order to provide the best possible service. After all, the better we understand our clients requirements, the more efficient and effective we will be."


Nathalie Huther

Business Development Manager Europe

Nathalie started her career as a synthetic and process chemist in drug discovery and development.

For the last 10 years, she has held various management positions in both tactical and strategic marketing and, more recently, in sales and business development, promoting services and products addressing the needs of the pharmaceutical and biotech markets in Europe, the Middle East and Africa.

Previous employers include Sigma-Aldrich, Excelsyn, AstraZeneca and Pharmorphix (now owned by Johnson Matthey).

Nathalie holds BSc and MSc degrees in Chemistry from the University of Strasbourg (France) and a PhD in Organic Chemistry from the University of York, and is fluent in French and German.

“I thrive in offering a consultative approach to sales and business development. Understanding our clients’ needs is key to ensure we offer the best solution to their specific requirements. I get the greatest satisfaction in the knowledge that we have successfully fulfilled those needs”